Joseph KAMGNO, is a Medical Doctor from the University of Yaounde I, with a Diploma of Epidemiology from Pasteur Institute in Paris, a Master of Public Health and a PhD in Epidemiology from the University of Paris VI.
He is currently teaching epidemiology at the Department of Public Health at the Faculty of Medicine and Biomedical Sciences at the University of Yaounde I where he was recently appointed Vice Dean in charge of Research and Cooperation. He is also Director of the Center for Research on Filariasis and other Tropical Diseases. He is since 2003 in charge of the post Mectizan and Albendazole Severe Adverse Events (SAEs) surveillance in Cameroon and has trained teams in all the Loa endemic countries in Central Africa for this surveillance.
Joseph KAMGNO is member of the Cameroon Academic of Sciences. He was part time Lecturer at the Louvain Catholic University in Belgium. He was awarded in 2015 the Islamic Development Bank Price for Sciences and Technology in recognition of his contribution at the socioeconomic development of his home country Cameroon. His main domains of research are onchocerciasis, loaisis, lymphatic filariasis (mapping, clinical trials, diagnostic tools, and post Mass Drug Administration impact evaluation). He has also done some work in the domain of epilepsy, malaria and Soil Transmitted helminths. He did complete mapping of Lymphatic filariasis and has also contributed in these diseases mapping in Central Africa. He is author and co-authors of 70 publications in peer review journals.